These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
226 related articles for article (PubMed ID: 23157058)
1. Quadruplet pregnancy complicated by ovarian hyperstimulation syndrome with spontaneous ovulation. Sugaya S; Hiroi T Clin Exp Obstet Gynecol; 2012; 39(3):402-4. PubMed ID: 23157058 [TBL] [Abstract][Full Text] [Related]
2. WITHDRAWN: Ovulation induction with urinary follicle stimulating hormone versus human menopausal gonadotropin for clomiphene-resistant polycystic ovary syndrome. Hughes E; Collins J; Vandekerckhove P Cochrane Database Syst Rev; 1996 Apr; (1):CD000087. PubMed ID: 17636586 [TBL] [Abstract][Full Text] [Related]
3. Gonadotrophins for ovulation induction in women with polycystic ovarian syndrome. Weiss NS; Nahuis M; Bayram N; Mol BW; Van der Veen F; van Wely M Cochrane Database Syst Rev; 2015 Sep; (9):CD010290. PubMed ID: 26350625 [TBL] [Abstract][Full Text] [Related]
4. Gonadotrophin therapy for ovulation induction in subfertility associated with polycystic ovary syndrome. Nugent D; Vandekerckhove P; Hughes E; Arnot M; Lilford R Cochrane Database Syst Rev; 2000; (4):CD000410. PubMed ID: 11034687 [TBL] [Abstract][Full Text] [Related]
5. Ovarian hyperstimulation syndrome associated with clomiphene citrate. Mitchell SY; Fletcher HM; Williams E West Indian Med J; 2001 Sep; 50(3):227-9. PubMed ID: 11769032 [TBL] [Abstract][Full Text] [Related]
6. Severe ovarian hyperstimulation syndrome in a naturally conceived singleton pregnancy after ovulation induction: a case report. Yang F; Hu H; He PZ; Zhang M; Qian Y; Li Y Clin Exp Obstet Gynecol; 2017; 44(2):292-295. PubMed ID: 29746043 [TBL] [Abstract][Full Text] [Related]
10. [Course of mole pregnancy complicated by ovarian hyperstimulation syndrome]. Diness M; Nilas L Ugeskr Laeger; 2012 May; 174(21):1465-7. PubMed ID: 22640792 [TBL] [Abstract][Full Text] [Related]
11. Consistent high clinical pregnancy rates and low ovarian hyperstimulation syndrome rates in high-risk patients after GnRH agonist triggering and modified luteal support: a retrospective multicentre study. Iliodromiti S; Blockeel C; Tremellen KP; Fleming R; Tournaye H; Humaidan P; Nelson SM Hum Reprod; 2013 Sep; 28(9):2529-36. PubMed ID: 23873146 [TBL] [Abstract][Full Text] [Related]
12. Pregnancy with 15 live fetuses and severe ovarian hyperstimulation syndrome after ovulation induction and intrauterine insemination. Abbas SM; Rouzi AA Clin Exp Obstet Gynecol; 2013; 40(2):297-9. PubMed ID: 23971265 [TBL] [Abstract][Full Text] [Related]
13. Severe ovarian hyperstimulation syndrome in patients with autoimmune disorders: a report of two cases. Kilpatrick CR; Ratts VS; Simckes E; McGill JB J Reprod Med; 2014; 59(11-12):591-5. PubMed ID: 25552133 [TBL] [Abstract][Full Text] [Related]
14. Spontaneous and iatrogenic ovarian hyperstimulation syndrome in the absence of FSHR mutations: a case report of two unexpected cases. Daolio J; Sperduti S; Casarini L; Falbo A; Materazzo C; Aguzzoli L; Villani MT BMC Med Genomics; 2023 Mar; 16(1):45. PubMed ID: 36882810 [TBL] [Abstract][Full Text] [Related]
16. Spontaneous ovarian hyperstimulation syndrome in a normal singleton pregnancy. Oztekin O; Soylu F; Tatli O Taiwan J Obstet Gynecol; 2006 Sep; 45(3):272-5. PubMed ID: 17175480 [TBL] [Abstract][Full Text] [Related]
17. Comparison of stimulation with clomiphene citrate in combination with recombinant follicle-stimulating hormone and recombinant luteinizing hormone to stimulation with a gonadotropin-releasing hormone agonist protocol: a prospective, randomized study. Weigert M; Krischker U; Pöhl M; Poschalko G; Kindermann C; Feichtinger W Fertil Steril; 2002 Jul; 78(1):34-9. PubMed ID: 12095487 [TBL] [Abstract][Full Text] [Related]
18. Strangulated internal hernia following severe ovarian hyperstimulation syndrome: a case report. Wei L; Zhang Y; Song X Gynecol Endocrinol; 2021 Jan; 37(1):93-96. PubMed ID: 33078979 [TBL] [Abstract][Full Text] [Related]
19. Laparoscopic drilling by diathermy or laser for ovulation induction in anovulatory polycystic ovary syndrome. Farquhar C; Brown J; Marjoribanks J Cochrane Database Syst Rev; 2012 Jun; (6):CD001122. PubMed ID: 22696324 [TBL] [Abstract][Full Text] [Related]
20. Octreotide is not useful for clomiphene citrate resistance in patients with polycystic ovary syndrome but may reduce the likelihood of ovarian hyperstimulation syndrome. Morris RS; Karande VC; Dudkiewicz A; Morris JL; Gleicher N Fertil Steril; 1999 Mar; 71(3):452-6. PubMed ID: 10065781 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]